30 Jan 2021
published in the journal
We present compelling conceptual evidence that targeting the AnxA1/FPR2/ALX pathway may provide new therapeutic possibilities against thromboinflammatory conditions such as Sickle Cell Disease.
30 Jul 2019
New paper pubished in the journal Circulation!
We present novel findings regarding the multifaceted role that AnxA1 plays in stroke. Such discovery could pave the way for novel and more personalized approaches to antiplatelet therapy.